Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1HYDROXYUREA

02 1Lithium Carbonate

03 1MERCAPTOPURINE

04 1Mercaptopurine

05 1Mercaptopurine Monohydrate

06 1Spironolakton

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : XROMI

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : XROMI

arrow
Aus. Peptide Conference
Not Confirmed

Nova Laboratories

Dosage Form : SOLUTION;ORAL

Brand Name : XROMI

Dosage Strength : 100MG/ML

Packaging :

Approval Date : 2024-04-04

Application Number : 216593

Regulatory Info : RX

Registration Country : USA

blank

02

Brand Name : Lithium Carbonate

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : Lithium Carbonate

arrow
Aus. Peptide Conference
Not Confirmed

Nova Laboratories

Dosage Form :

Brand Name : Lithium Carbonate

Dosage Strength : 50 Cpr 300 Mg ...

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : United Kingdom

blank

03

Brand Name : PURIXAN

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : PURIXAN

arrow
Aus. Peptide Conference
Not Confirmed

Nova Laboratories

Dosage Form : SUSPENSION;ORAL

Brand Name : PURIXAN

Dosage Strength : 20MG/ML

Packaging :

Approval Date : 2014-04-28

Application Number : 205919

Regulatory Info : RX

Registration Country : USA

blank

04

Brand Name : Xaluprine

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : Xaluprine

arrow
Aus. Peptide Conference
Not Confirmed

Nova Laboratories

Dosage Form : Oral Suspension

Brand Name : Xaluprine

Dosage Strength : 20MG

Packaging :

Approval Date : 2013-02-05

Application Number : 11727001

Regulatory Info : Authorized

Registration Country : Spain

blank

05

Brand Name : Xaluprine

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : Xaluprine

arrow
Aus. Peptide Conference
Not Confirmed

Nova Laboratories

Dosage Form : Oral Suspension

Brand Name : Xaluprine

Dosage Strength : 20mg/ml

Packaging :

Approval Date : 09/03/2012

Application Number : 20100604000100

Regulatory Info : Approved

Registration Country : Sweden

blank

06

Brand Name : Qaialdo

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : Qaialdo

arrow
Aus. Peptide Conference
Not Confirmed

Nova Laboratories

Dosage Form : Oral Suspension

Brand Name : Qaialdo

Dosage Strength : 10mg/ml

Packaging :

Approval Date : 26/05/2023

Application Number : 20211104000023

Regulatory Info : Approved

Registration Country : Sweden

blank